产品名称
二氧化硅, Monodisperse, non-porous, 40 µm
InChI key
VYPSYNLAJGMNEJ-UHFFFAOYSA-N
InChI
1S/O2Si/c1-3-2
SMILES string
O=[Si]=O
form
powder
particle size
40 μm
pore size
non-porous
bp
2230 °C (lit.)
mp
>1600 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
Our monodisperse non-porous silica particles have a uniform particle size of 40 µm and a narrow size distribution. Furthermore, these particles are non-porous, meaning they do not contain any internal void spaces. This feature renders their surfaces impermeable to fluids and gases. Additionally, their monodispersity contributes to excellent dispersion properties, allowing them to disperse evenly and maintain stability in a range of solvents, suspensions, or matrices.
Application
Monodispersed non-porous silica particles find use in various applications such as fillers or additives in composites, coatings, paints, and polymers to enhance mechanical properties or provide unique functionalities. Additionally, these particles find utility in diagnostics, drug delivery systems, sensors, catalysis, and environmental remediation. Their tailored size, uniformity, and stable surfaces contribute to their effectiveness in these applications. The silica particle surface exhibits a highly modifiable chemistry that allows for easy passive functionalization with a variety of biomolecules. The silica particles can also be modified with different functional groups, which can serve as a scaffold for the covalent attachment of biological components such as dextran, antibodies, DNA, or peptides.,
存储类别
11 - Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Ja-Yeon Kim et al.
Scientific reports, 7(1), 14566-14566 (2017-11-08)
Nonporous silica nanoparticles (SiNPs) are promising drug carrier platforms for intraocular drug delivery. In this study, we investigated the safety of three different sizes of SiNPs (50, 100, and 150 nm) in a human corneal endothelial cell (HCEC) line, B4G12. The
Sean E Lehman et al.
Langmuir : the ACS journal of surfaces and colloids, 32(3), 731-742 (2015-12-31)
Understanding complex chemical changes that take place at nano-bio interfaces is of great concern for being able to sustainably implement nanomaterials in key applications such as drug delivery, imaging, and environmental remediation. Typical in vitro assays use cell viability as
Li Tang et al.
Nano today, 8(3), 290-312 (2013-09-03)
Nanomedicine, the use of nanotechnology for biomedical applications, has potential to change the landscape of the diagnosis and therapy of many diseases. In the past several decades, the advancement in nanotechnology and material science has resulted in a large number
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持